Sio Gene Therapies Inc. Quarterly Debt-to-equity in % from Q4 2015 to Q4 2022

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Sio Gene Therapies Inc. quarterly Debt-to-equity history and growth rate from Q4 2015 to Q4 2022.
  • Sio Gene Therapies Inc. Debt-to-equity for the quarter ending December 31, 2022 was 15.7 %, a 33.7% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2022 15.7 +3.96 +33.7% Dec 31, 2022
Q3 2022 19.9 +10.2 +105% Sep 30, 2022
Q2 2022 18.6 +8.44 +82.7% Jun 30, 2022
Q1 2022 14.7 +1.74 +13.4% Mar 31, 2022
Q4 2021 11.8 -11.4 -49.2% Dec 31, 2021
Q3 2021 9.74 -37.4 -79.4% Sep 30, 2021
Q2 2021 10.2 -88.8 -89.7% Jun 30, 2021
Q1 2021 13 -164 -92.7% Mar 31, 2021
Q4 2020 23.2 -195 -89.4% Dec 31, 2020
Q3 2020 47.2 -169 -78.2% Sep 30, 2020
Q2 2020 99 -131 -56.9% Jun 30, 2020
Q1 2020 177 -66.4 -27.2% Mar 31, 2020
Q4 2019 218 -15.9 -6.78% Dec 31, 2019
Q3 2019 216 +62.7 +40.9% Sep 30, 2019
Q2 2019 230 +130 +132% Jun 30, 2019
Q1 2019 244 +174 +249% Mar 31, 2019
Q4 2018 234 +169 +261% Dec 31, 2018
Q3 2018 154 +102 +200% Sep 30, 2018
Q2 2018 99.2 +61 +160% Jun 30, 2018
Q1 2018 69.8 +45 +181% Mar 31, 2018
Q4 2017 64.9 +53.4 +465% Dec 31, 2017
Q3 2017 51.2 +43.5 +563% Sep 30, 2017
Q2 2017 38.2 +32.9 +618% Jun 30, 2017
Q1 2017 24.8 +20.5 +471% Mar 31, 2017
Q4 2016 11.5 +6.59 +135% Dec 31, 2016
Q3 2016 7.72 Sep 30, 2016
Q2 2016 5.32 Jun 30, 2016
Q1 2016 4.34 Mar 31, 2016
Q4 2015 4.89 Dec 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.